Bioniq Raises $15M to Extend AI-Driven Personalized Supplements to Users Globally
London-based health tech startup specializing in AI-driven supplements by leveraging blood biomarker data, Bioniq, has secured $15 million in an oversubscribed series B funding round to expand its global market share and continue disrupting the dietary supplements market.
Co-founded in 2019 by Vadim Fedotov and Constantin Karuzin, Bionic is currently valued at $75 million. The company’s latest funding round was ... moreBioniq Raises $15M to Extend AI-Driven Personalized Supplements to Users Globally
London-based health tech startup specializing in AI-driven supplements by leveraging blood biomarker data, Bioniq, has secured $15 million in an oversubscribed series B funding round to expand its global market share and continue disrupting the dietary supplements market.
Co-founded in 2019 by Vadim Fedotov and Constantin Karuzin, Bionic is currently valued at $75 million. The company’s latest funding round was co-led by leading European venture capital firms HV Capital and Unbound.
